FRESENIUS MED CARE AG&CO KGA's ticker is FMS and the CUSIP is 358029106. A total of 148 filers reported holding FRESENIUS MED CARE AG&CO KGA in Q4 2015. The put-call ratio across all filers is 25.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $588,163 | -18.2% | 27,306 | -9.1% | 0.00% | 0.0% |
Q2 2023 | $718,823 | +43.9% | 30,039 | +27.8% | 0.00% | 0.0% |
Q1 2023 | $499,559 | +81.8% | 23,498 | +39.7% | 0.00% | – |
Q4 2022 | $274,783 | -6.9% | 16,817 | +137.1% | 0.00% | -100.0% |
Q4 2020 | $295,000 | -3.6% | 7,093 | -1.6% | 0.00% | 0.0% |
Q3 2020 | $306,000 | -7.0% | 7,208 | -5.2% | 0.00% | 0.0% |
Q2 2020 | $329,000 | +37.7% | 7,604 | +4.3% | 0.00% | 0.0% |
Q1 2020 | $239,000 | -0.8% | 7,288 | +11.3% | 0.00% | 0.0% |
Q4 2019 | $241,000 | +10.6% | 6,550 | +1.0% | 0.00% | 0.0% |
Q3 2019 | $218,000 | -13.8% | 6,483 | +0.5% | 0.00% | 0.0% |
Q2 2019 | $253,000 | -7.3% | 6,452 | -4.0% | 0.00% | 0.0% |
Q1 2019 | $273,000 | +17.7% | 6,724 | -6.1% | 0.00% | 0.0% |
Q4 2018 | $232,000 | -47.9% | 7,157 | -17.2% | 0.00% | -50.0% |
Q3 2018 | $445,000 | +3.2% | 8,645 | +1.1% | 0.00% | 0.0% |
Q2 2018 | $431,000 | -1.6% | 8,551 | -0.2% | 0.00% | 0.0% |
Q1 2018 | $438,000 | -9.7% | 8,567 | -7.1% | 0.00% | 0.0% |
Q4 2017 | $485,000 | +14.7% | 9,225 | +6.7% | 0.00% | 0.0% |
Q3 2017 | $423,000 | +4.4% | 8,645 | +3.2% | 0.00% | 0.0% |
Q2 2017 | $405,000 | +11.6% | 8,374 | -2.8% | 0.00% | 0.0% |
Q1 2017 | $363,000 | +0.8% | 8,615 | +1.1% | 0.00% | 0.0% |
Q4 2016 | $360,000 | +9.4% | 8,519 | +13.4% | 0.00% | 0.0% |
Q3 2016 | $329,000 | +5.1% | 7,511 | +4.7% | 0.00% | 0.0% |
Q2 2016 | $313,000 | -0.3% | 7,173 | +0.7% | 0.00% | 0.0% |
Q1 2016 | $314,000 | -7.1% | 7,126 | -11.8% | 0.00% | -33.3% |
Q4 2015 | $338,000 | +22.0% | 8,078 | +13.6% | 0.00% | +50.0% |
Q3 2015 | $277,000 | +1008.0% | 7,111 | +1063.8% | 0.00% | – |
Q1 2015 | $25,000 | -10.7% | 611 | -19.6% | 0.00% | – |
Q4 2014 | $28,000 | +33.3% | 760 | +28.4% | 0.00% | – |
Q3 2014 | $21,000 | +133.3% | 592 | +131.2% | 0.00% | – |
Q2 2014 | $9,000 | -43.8% | 256 | -45.2% | 0.00% | – |
Q1 2014 | $16,000 | -5.9% | 467 | 0.0% | 0.00% | – |
Q4 2013 | $17,000 | +13.3% | 467 | 0.0% | 0.00% | – |
Q3 2013 | $15,000 | -6.2% | 467 | +3.3% | 0.00% | – |
Q2 2013 | $16,000 | – | 452 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lombard Odier & Cie (Canada), Limited Partnership | 12,500 | $523,000 | 1.34% |
Norman Fields, Gottscho Capital Management, LLC | 35,747 | $1,496,000 | 1.06% |
SEARLE & CO. | 23,288 | $961,000 | 0.92% |
HARDING LOEVNER LP | 2,267,696 | $94,188,000 | 0.76% |
MARATHON ASSET MANAGEMENT LLP | 719,924 | $30,251,000 | 0.68% |
Ativo Capital Management LLC | 63,171 | $2,643,000 | 0.66% |
Lombard Odier Transatlantic Ltd | 8,300 | $349,000 | 0.30% |
BEESE FULMER INVESTMENT MANAGEMENT, INC. | 20,160 | $843,000 | 0.26% |
MITCHELL MCLEOD PUGH & WILLIAMS INC | 5,300 | $222,000 | 0.22% |
Hardman Johnston Global Advisors LLC | 68,821 | $2,879,000 | 0.19% |